Six RCTs [17, 18, 3235] involving 417 patients provided moderate certainty evidence (Table 2) that L-carnitine supplementation has no difference in changes in the BMI (MD: 0.00, 95%CI: 0.23 to 0.24)
Dick KJ, Nelson CP, Tsaprouni L, Sandling JK, Assi D, Wahl S, et al
Since the peptide is stable in the gut, it can be delivered without special carriers or currently known toxicity
This guide explains Retatrutide's mechanism of action in detail, covering triple hormone receptor agonism, molecular structural features, downstream signalling, and the pharmacological rationale that has positioned Retatrutide as the most advanced triple agonist in clinical development
Do NOT combine unless under strict medical supervision